EVELO BIOSCIENCES, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule
or Standard; Transfer of Listing.

On April 25, 2023, Evelo Biosciences, Inc. received a letter
from the Listing... | May 1, 2023

Related Keywords

United States , ,Exchange Commission ,Listing Qualifications Department Of Nasdaq ,Nasdaq Stock Market ,Evelo Biosciences Inc ,Company Common Stock ,Nasdaq Listing Qualifications Panel ,Listing Qualifications Department ,Nasdaq ,Continued Listing Rule ,Minimum Value ,Nasdaq Global Select Market ,Nasdaq Listing Rule ,Market Value ,Listed Securities ,Qualifications Department ,Publicly Held Shares ,Common Stock ,Nasdaq Global Select ,Minimum Market Value ,Listed Securities Requirement ,Publicly Held Shares Requirement ,Listing Qualifications ,Nasdaq Capital Market ,Current Report ,Private Securities Litigation Reform Act ,Nasdaq Capital ,Annual Report ,States Securities ,Edgar Online ,Evelo Biosciences ,Nc Stock Exchange ,News ,Information ,Press Release ,Item ,Notice ,F ,Elisting ,Dr ,Failure ,O ,Asatisfy ,Ontinued ,Listing ,Transfer ,Pril ,Zvelo ,Eceived ,He Evlo Us2997341035 ,